US Medtech Lobbyists Say They're Not Worried About Political Backlash From 'Implant Files'
Executive Summary
The International Consortium of Investigative Journalists started publishing the findings of its "Implant Files" investigation last month, but the two main industry groups in the US have not picked up any significant political backlash resulting from the reporting so far.
You may also be interested in...
Ad Hominis: FDA Authorizes Memic Innovative’s Surgical Robot
The device can conduct laparoscopic hysterectomies, giving surgeons more mobility while leaving less scarring.
After A Year Of Pelvic Mesh Criticism, US FDA Calls Meeting To Discuss The Beleaguered Products
Following a number of reports and a major documentary criticizing the use of surgical mesh in transvaginal surgeries, regulators are calling on an expert panel and other stakeholders to provide recommendations on their safety and effectiveness.
Into 2019: Intelligent Innovation's Role In The Shape Of Medtech Things To Come
Brexit, the "Implant Files" and the new EU regulations – however large they loom at present, they will in time be seen as mere tactical challenges for a global medtech industry working hard to ensure that it is ready for the massive health-care delivery and service-oriented changes to come. Preparing for the future and maximizing current market penetration – in the UK, the EU and beyond – were key themes at UK HealthTech 2018, held in Cardiff, Wales.